Adjustment Disorders: Clinical Trials

3 trials for Adjustment Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Adjustment Disorders: new trials by email Literature Review of Adjustment Disorders trials Research Report on Adjustment Disorders

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders
Ranquilon, Placebo - Anxiety, Neurasthenia
Phase 3CompletedValenta Pharm JSC2202022-10-122023-07-27
The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol
Propranolol Pill - Adjustment Disorders, Posttraumatic Stress Disorder
Phase 2 / Phase 3CompletedDouglas Mental Health University Institute842015-11-012022-12-19
Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
Risperdal - Oppositional Defiant Disorder, Conduct Disorder
Phase 3CompletedOhio State University301999-05-012016-06-23

Narrower conditions

Anxiety Disorders (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Bipolar Disorder (1)  ·  Child Development Disorders, Pervasive (1)  ·  Conduct Disorder (1)  ·  Disruptive, Impulse Control, and Conduct Disorders (1)  ·  Neurasthenia (1)  ·  Oppositional Defiant Disorder (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Trauma and Stressor Related Disorders (1)

Broader conditions

Mental Disorders (3)  ·  Trauma and Stressor Related Disorders (2)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Bipolar and Related Disorders (1)  ·  Mood Disorders (1)  ·  Neurodevelopmental Disorders (1)  ·  Somatoform Disorders (1)  ·  Stress Disorders, Traumatic (1)

Interventions

GB-115 (1)  ·  Propranolol (1)  ·  Risperidone (1)

Sponsors

Douglas Mental Health University Institute (1)  ·  Ohio State University (1)  ·  Valenta Pharm JSC (1)

Countries

Canada (1)  ·  Russia (1)  ·  United States (1)

Top investigators

Michael G Aman, Ph.D. (1)

Results publications

PMID 36031005